Vathiotis et al. conducted a study on human lung cancer and observed that among 455 patients with NSCLC, 25% exhibited CD200R overexpression, particularly in the stromal regions of patients with squamous differentiation [111]. This evidence concerns the gene CD200R1 and non-small cell lung carcinoma.